This dual role—protective in physiological contexts yet deleterious in malignancy—positions CYP24A1 as both a biomarker of tumor aggressiveness and a promising therapeutic target in colorectal cancer [28,103,106]. The gene discussed is CYP24A1; the disease is neoplasm.